D4265 Dental Code: Biologic Materials for Tissue Regeneration (Billing Guide 2026)

Reviewed by Morgan Heminger · Updated September 23, 2026

What Is D4265? (CDT Code Overview)

CDT code D4265 is the dental procedure code for biologic materials to aid in soft and osseous tissue regeneration, per site, such as enamel matrix derivative applied during periodontal surgery. It is reported in addition to the surgery and any bone graft or membrane, which have their own codes. It belongs to the Periodontics category of CDT codes (Surgical Services subcategory). The D4265 dental code covers the biologic only; when used with periradicular (endodontic) surgery the code is D3431.

When Should You Use D4265?

The D4265 dental code applies to procedures involving biologic materials that promote soft and hard tissue regeneration. This CDT code is typically utilized in periodontal surgical treatments where practitioners employ biologic substances, including growth factors or bone morphogenetic proteins, to support the body's natural healing processes for bone and soft tissue restoration. Common applications include guided tissue regeneration procedures, ridge preservation techniques, or cases where standard bone grafting methods alone may not provide optimal outcomes. It's crucial to understand that D4265 is not intended for bone graft materials by themselves; it specifically addresses the biologic enhancement component of these treatments.

Quick reference: Use D4265 when the clinical scenario specifically matches biologic materials for tissue regeneration. Do not use this code as a substitute for related procedures in the same category. Consider whether D4210 (Gingivectomy and Gingivoplasty Procedures) or D4211 (Single-Tooth Gingivectomy and Gingivoplasty) might be more appropriate instead.

D4265 vs. Similar CDT Codes: Key Differences

Dental teams frequently confuse D4265 with other codes in the periodontal scaling/root planing range. Here is how D4265 differs from the most commonly mixed-up codes:

Documentation Requirements for D4265

Proper documentation plays a vital role in securing successful reimbursement for D4265. Dental practices must ensure their clinical records thoroughly describe:

• The particular biologic substance utilized (such as platelet-derived growth factor or enamel matrix derivative).
• The clinical justification for its application, including insufficient natural bone or soft tissue for proper regeneration.
• Comprehensive details of the treatment site and surgical procedure (such as periodontal defect repair or ridge augmentation).
• Before and after radiographic images or clinical photographs where applicable.

Typical clinical applications involve addressing intrabony defects, furcation involvement cases, or site preparation for future implant procedures. Always verify that the biologic material is not combined with other codes, such as bone replacement grafts (D4263), unless the insurance carrier explicitly permits such bundling.

Documentation checklist for D4265:

• Patient chief complaint and relevant medical/dental history clearly recorded.
• Clinical findings that support the use of D4265 specifically (not a more general or more specific code).
• Any diagnostic tests, imaging, or supplementary data that justify the procedure.
• Treatment plan with rationale connecting the diagnosis to the procedure coded as D4265.
• Post-procedure notes, including outcomes and follow-up recommendations.

For a deeper look at documentation best practices, see our guide on 6 Dental Hygienist Charting Mistakes that Cause Claim Denials.

Insurance and Billing Guide for D4265

Processing claims for D4265 demands careful attention to insurance policies and documentation requirements. Here are practical strategies for improving claim approval rates:

• Confirm benefits prior to treatment: Numerous dental insurance plans classify D4265 as a "by report" service or exclude it from coverage. Contact the insurance provider to determine benefit availability and whether prior authorization is necessary.
• Provide comprehensive narratives: When submitting claims, include detailed explanations of the medical necessity for the biologic material, backed by clinical observations and imaging studies.
• Include supporting materials: Always provide operative notes, clinical images, and manufacturer documentation regarding the material's regenerative capabilities.
• Examine EOBs thoroughly: If claims are rejected, review the Explanation of Benefits for denial reasons and prepare to file appeals with additional supporting evidence when appropriate.

Taking a proactive approach to benefit verification and maintaining detailed documentation can substantially enhance reimbursement success for D4265.

Common denial reasons for D4265: Lack of clinical documentation, frequency limitations exceeded, code mismatch with diagnosis, or missing prior authorization. When appealing a denied D4265 claim, include a detailed narrative explaining why the procedure was necessary, supporting clinical evidence, and relevant imaging or test results. Many practices find that well-documented first submissions dramatically reduce the need for appeals.

What major payers publish about D4265:

• Aetna asks for a narrative plus the material, agents and drugs used. It bases medical necessity on infrabony defects without furcations caused by moderate or severe periodontitis (Aetna Claim Documentation Guidelines, July 2025; Aetna Dental Clinical Policy Bulletin 005, July 2025).
• Cigna allows D4265 when pockets are 5 mm or deeper with bone loss and it is the only regenerative treatment at the site. It is not allowed with other regrowth treatment at the same site and date, at an extraction site, or when the same office repeats it on the same site within 36 months (Cigna Dental Coverage Determination Guidelines, 2026).
• UnitedHealthcare needs a narrative of necessity naming the material and how it was applied. Its policy supports enamel matrix derivative and bioactive glass only, and not with periradicular surgery or for mucogingival defects (UnitedHealthcare Dental Claim Review Guidelines, January 2026; UnitedHealthcare Biologic Materials for Dental Indications policy DCP047.05, May 2026).
• Delta Dental of Virginia benefits D4265 on natural teeth only, with flap surgery (D4240, D4241, D4245, D4260, D4261), once per site per 36 months, and denies it when billed with a bone graft, GTR, soft tissue graft or scaling and root planing at the same site (Delta Dental of Virginia Participating Dentists' Handbook, 2026).

These are the payers' published policy documents; the patient's own plan can set different frequencies and alternate benefits, so confirm them during insurance verification.

To improve your overall claims workflow, explore How to Address 5 Common Dental Insurance Misconceptions with Patients.

Real-World Case Example: Billing D4265

A patient presents requiring a procedure consistent with D4265 (biologic materials for tissue regeneration). The treating dentist documents the clinical findings, performs the procedure as indicated, and records detailed notes including the diagnosis, technique, and outcome. The billing team verifies insurance coverage, submits the claim with D4265 and supporting documentation, and follows up to ensure timely reimbursement. When the initial claim is processed, the practice reviews the Explanation of Benefits and addresses any discrepancies promptly.

Related CDT Codes to D4265

If you are researching D4265, you may also need to reference these related CDT codes in the periodontal scaling/root planing range and beyond:

• D4210: Gingivectomy and Gingivoplasty Procedures — Learn when to use D4210 and how it differs from D4265.
• D4211: Single-Tooth Gingivectomy and Gingivoplasty — Learn when to use D4211 and how it differs from D4265.
• D4212: Gingivectomy for Restorative Access — Learn when to use D4212 and how it differs from D4265.
• D4230: Crown Exposure for Four or More Teeth — Learn when to use D4230 and how it differs from D4265.
• D4231: Anatomical Crown Exposure Procedure — Learn when to use D4231 and how it differs from D4265.

Frequently Asked Questions About D4265

Is D4265 appropriate for billing in non-surgical treatments?

D4265 cannot be billed for non-surgical treatments. This code is exclusively designed for surgical procedures involving the placement of biologic materials to promote soft tissue or bone regeneration. The billing must be supported by clinical justification within a surgical treatment context, and it is not applicable for preventive or non-surgical care. Always verify with the specific insurance carrier, as policies and coverage rules can vary significantly between payers. Maintaining thorough documentation for D4265 will strengthen your position in any audit or appeal scenario.

What are typical reasons insurance companies reject D4265 claims?

Insurance rejections for D4265 commonly occur due to inadequate documentation demonstrating medical necessity, missing pre-authorization requirements, billing D4265 when it's already bundled with another procedure code, or when the patient's dental benefits exclude coverage for biologic materials. Practices can minimize denials by maintaining comprehensive documentation and confirming insurance coverage prior to treatment. Always verify with the specific insurance carrier, as policies and coverage rules can vary significantly between payers. Maintaining thorough documentation for D4265 will strengthen your position in any audit or appeal scenario.

What's the best approach for discussing D4265 costs with patients?

Dental practices should proactively discuss potential out-of-pocket expenses with patients before treatment begins, especially when insurance may not cover D4265. This conversation should include explaining the therapeutic value of biologic materials, providing detailed cost estimates, and securing written informed consent. Transparent communication helps set appropriate expectations and enhances the patient experience. Always verify with the specific insurance carrier, as policies and coverage rules can vary significantly between payers. Maintaining thorough documentation for D4265 will strengthen your position in any audit or appeal scenario.

What is the typical reimbursement range for D4265?

2026 Medicaid fee schedules give a public reference point for D4265: Medi-Cal Dental treats it as a global procedure with no separate fee (Medi-Cal Dental Schedule of Maximum Allowances, July 2026). D4265 is not a covered, separately priced service on the New York Medicaid, Florida Medicaid or Texas THSteps fee schedules. Commercial PPO reimbursement depends on the payer contract, your region and network status, so the most reliable number for your practice is the allowed amount on your recent EOBs for D4265.

Does D4265 require prior authorization?

Prior authorization requirements for D4265 depend on the patient's specific insurance plan. Some carriers require advance approval for procedures coded under D4265, while others process claims without it. Best practice is to verify authorization requirements during insurance eligibility checks before the appointment. If prior authorization is required, submit the request with detailed clinical notes and supporting documentation to avoid delays in patient care and claim processing.